Abstract
Cutaneous mucormycosis is an uncommon disease and occurs mainly in immunocompromised patients. We report an immunocompetent infant who developed primary cutaneous mucormycosis at an intravenous line site secured with an arm board and elastic bandage. The isolate was identified as the zygomycete, Rhizopus sp. High mortality rates are reported with invasive mucormycosis; however, early identification of the causative agent and antifungal therapy led to complete cure of the lesions in the reported case.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
